Quadrant Capital Group LLC Ngm Biopharmaceuticals Inc Transaction History

Quadrant Capital Group LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$2.44 - $4.53 $63 - $117	26 Added 32.5%	106 $0
Q1 2023 May 11, 2023	BUY	$3.72 - $5.4 $297 - $432	80 New	80 $0
Q2 2022 Aug 09, 2022	BUY	$10.58 - $17.5 $232 - $385	22 New	22 $0
Q1 2022 May 06, 2022	SELL	$13.81 - $18.6 $290 - $390	-21 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$17.26 - $22.02 $69 - $88	-4 Reduced 16.0%	21 $0
Q3 2021 Nov 12, 2021	BUY	$20.15 - $26.19 $503 - $654	25 New	25 $1,000
Q2 2021 Aug 09, 2021	SELL	$15.06 - $30.03 $406 - $810	-27 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$24.99 - $31.93 $674 - $862	27 New	27 $1,000
Q2 2020 Aug 13, 2020	SELL	$11.97 - $23.47 $502 - $985	-42 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$10.0 - $19.51 $420 - $819	42 New	42 $1,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.